Integer Holdings Corp (New York Stock Exchange:ITGR)
| Market Cap | $4.32B+78.3% |
| Revenue (ttm) | $1.82B-0.0% |
| Net Income | $103.70M+19.4% |
| EPS | $2.98+24.7% |
| Shares Out | 34.00M |
| PE Ratio | 42.32 |
| Forward PE | 18.64 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 798,710 |
| Open | $126.93 |
| Previous Close | $126.95 |
| Day's Range | $126.93 - $132.39 |
| 52-Week Range | $66.51 - $133.06 |
| Beta | 0.58 |
| Analysts | Buy |
| Price Target | $119.33(-6.02%) |
| Earnings Date | Feb 18, 2027 |
About ITGR
Integer Holdings Corporation functions as a global leader in outsourced medical device manufacturing, maintaining operations across the United States, Puerto Rico, Costa Rica, and other international regions. The company organizes its business into two primary divisions: Medical and Non-Medical. Within its Medical segment, Integer delivers a broad array of devices and components essential for numerous advanced medical procedures. These solutions cater to areas such as interventional cardiology, structural heart conditions, heart failure management, peripheral and neurovascular interventions, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology. Their extensive product portfolio includes cardiac rhythm management devices like implantable pacemakers, defibrillators, cardiac monitors, leads, and heart failure therapies. They also produce neuromodulation devices, such as implantable spinal cord stimulators, alongside critical components like non-rechargeable batteries, feedthroughs, device enclosures, precision-machined parts, and lead sub-assemblies. Furthermore, Integer provides rechargeable battery systems and chargers. A comprehensive range of surgical instruments and components is also offered for arthroscopic, laparoscopic, and general surgery, encompassing items like harmonic scalpels, various blades and shavers, radio frequency and biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment parts, and phacoemulsification needles. Orthopedic offerings comprise specialized instruments for hip, knee, and spine surgeries, including reamers and chisels, among other general medical technologies. The Non-Medical segment concentrates on developing customized battery power and management systems, along with specialized battery solutions, designed for the energy, military, and environmental sectors. Integer primarily collaborates with multinational original equipment manufacturers (OEMs) and their affiliated subsidiaries, supporting their requirements across diverse markets, including cardiac, neuromodulation, orthopedics, vascular, advanced surgical, and portable medical applications. Established in 1970, Integer Holdings Corporation is headquartered in Plano, Texas.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Next catalysts
- Feb 18, 2027Earnings report
$ITGR stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in ITGR holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by ITGR's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
ITGR Estimated quarterly lobbying spending
Source: U.S. Senate LDA
ITGR Revenue by Segment or Geography
| Cardio & Vascular | $263.08M | 58.51% |
| Cardiac Rhythm Management & Neuromodulation | $175.84M | 39.10% |
| Other Markets | $10.75M | 2.39% |
As of: Q4 2026 (Oct 2, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New ITGR patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to ITGR from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in ITGR
| VTIVanguard Morningstar Total Stock Market ETF | $107.89M |
| VBVanguard Morningstar Small-Cap ETF | $96.54M |
| VBRVanguard Morningstar Small-Cap Value ETF | $62.71M |
| VXFVanguard Extended Market ETF | $48.76M |
| VTWOVanguard Russell 2000 ETF | $25.54M |
| VIOOVanguard S&P Small-Cap 600 ETF | $15.38M |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from ITGR’s recent data — informational, not investment advice
What’s Behind the Score
News check: KKR acquisition completed successfully, but analyst downgraded price target while maintaining buy, suggesting mixed near-term outlook.
Recent Insider Activity
Insider Score Trend Over Time
+0.0 since Sep 11Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.
Frequently Asked Questions
ETFs that hold this stock
| MNA | NYLI Merger Arbitrage ETF | 2.48% |
| MRGR | ProShares - Merger ETF | 2.33% |
| PSCH | Invesco S&P SmallCap Health Care ETF | 2.27% |
| EVNT | AltShares Event-Driven ETF | 2.03% |
| ARB | AltShares Merger Arbitrage ETF | 1.94% |
| XHE | State Street SPDR S&P Health Care Equipment ETF | 1.53% |
| SVAL | iShares US Small Cap Value Factor ETF | 0.56% |
| IHI | iShares U.S. Medical Devices ETF | 0.53% |
| VIOV | Vanguard S&P Small-Cap 600 Value ETF | 0.48% |
| SQLV | Royce Quant Small-Cap Quality Value ETF | 0.46% |
| SLYV | State Street SPDR S&P 600 Small Cap Value ETF | 0.46% |
| IJS | iShares S&P Small-Cap 600 Value ETF | 0.46% |
Weight is the stock’s share of each fund’s holdings.
